AIDS and HIV Vaccine
Live recombinant vectors used for AIDS vaccine development
Published in Vaccine Weekly, July 23rd, 2003
According to published research from the United States, "Live recombinant vectors entered the AIDS vaccine field with the realization that live attenuated HIV vaccines posed too great a safety risk, and that subunit vaccines elicited antibodies which lacked the breadth or potency needed to induce sterilizing immunity. Vectored vaccines provided a means to bring the cellular arm of the immune system into play by mimicking natural viral infection. By delivering antigens within host cells, processing and presentation could occur for induction of cellular immune responses."
"This...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-07-23)
More Articles from Vaccine Weekly
- Creutzfeldt-Jakob Disease
Brain innoculation with attenuated prions protects indefinitely from virulence - Diarrhea Vaccine
E. coli vaccine elicits strong immune response in Bangladeshi children - Influenza Vaccine
Anti-hemagglutinin IgG on alveolar epithelia play key role to prevent influenza - AIDS and HIV Vaccine
Menstrual cycle affects mucosal immunity to SHIV in baboons - Hepatitis E Vaccine
Hepatitis E virus infection may be zoonosis - Polio Vaccine
Unsafe glass syringes associated with HCV transmission in southern Italy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
